Cargando…

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins

14-3-3s represent a family of highly conserved 30 kDa acidic proteins. 14-3-3s recognize and bind specific phospho-sequences on client partners and operate as molecular hubs to regulate their activity, localization, folding, degradation, and protein–protein interactions. 14-3-3s are also associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giusto, E., Yacoubian, T. A., Greggio, E., Civiero, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455551/ https://www.ncbi.nlm.nih.gov/pubmed/34548498 http://dx.doi.org/10.1038/s41531-021-00230-6

Ejemplares similares

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
por: Greggio, Elisa, et al.
Publicado: (2011)

Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?
por: Greggio, Elisa, et al.
Publicado: (2012)

Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease
por: Yacoubian, T A, et al.
Publicado: (2010)

Ceramides in Parkinson’s Disease: From Recent Evidence to New Hypotheses
por: Plotegher, Nicoletta, et al.
Publicado: (2019)

Spotlight on the NLRP3 inflammasome pathway
por: Groslambert, Marine, et al.
Publicado: (2018)

Genetic, Structural, and Molecular Insights into the Function of Ras of Complex Proteins Domains
por: Civiero, Laura, et al.
Publicado: (2014)

14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax
por: Slone, Sunny R., et al.
Publicado: (2011)

PGC-1s in the Spotlight with Parkinson’s Disease
por: Piccinin, Elena, et al.
Publicado: (2021)

Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
por: McFerrin, Michael B., et al.
Publicado: (2017)

14-3-3 phosphorylation inhibits 14-3-3θ’s ability to regulate LRRK2 kinase activity
por: Pattanayak, Rudradip, et al.
Publicado: (2023)

Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease
por: Raghunathan, Rekha, et al.
Publicado: (2022)

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
por: Streubel-Gallasch, Linn, et al.
Publicado: (2021)

Glial phagocytic clearance in Parkinson’s disease
por: Tremblay, Marie-Eve, et al.
Publicado: (2019)

Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
por: Lobbestael, E., et al.
Publicado: (2016)

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
por: Iovino, Ludovica, et al.
Publicado: (2022)

Myeloma Bone Disease: The Osteoblast in the Spotlight
por: Andrews, Rebecca E., et al.
Publicado: (2021)

Spotlight on the SAPIEN 3 transcatheter heart valve
por: Rheude, Tobias, et al.
Publicado: (2018)

PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
por: Civiero, Laura, et al.
Publicado: (2017)

Spotlight on Plant Bromodomain Proteins
por: Bardani, Eirini, et al.
Publicado: (2023)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Spotlight on opicapone as an adjunct to levodopa in Parkinson’s disease: design, development and potential place in therapy
por: Annus, Ádám, et al.
Publicado: (2017)

GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1
por: Jebelli, Joseph D., et al.
Publicado: (2012)

Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions
por: Greggio, Elisa, et al.
Publicado: (2009)

GTP binding controls complex formation by the human ROCO protein MASL1
por: Dihanich, Sybille, et al.
Publicado: (2014)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
por: Jiang, Chunteng, et al.
Publicado: (2021)

Spotlight on protein N-terminal acetylation
por: Ree, Rasmus, et al.
Publicado: (2018)

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
por: Underwood, Rachel, et al.
Publicado: (2021)

Focusing the spotlight on GSK-3 in aging
por: Zhou, Jibin, et al.
Publicado: (2013)

The role of 14‐3‐3 proteins in cell signalling pathways and virus infection
por: Liu, Jiaqi, et al.
Publicado: (2021)

Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells
por: Calvani, Maura, et al.
Publicado: (2019)

Integrins in the Spotlight of Cancer
por: Bianconi, Daniela, et al.
Publicado: (2016)

Spotlight on fundus autofluorescence
por: Calvo-Maroto, Ana M, et al.
Publicado: (2018)

Spotlight on math anxiety
por: Luttenberger, Silke, et al.
Publicado: (2018)

Spotlight on reticular pseudodrusen
por: Rabiolo, Alessandro, et al.
Publicado: (2017)

Neuroprotective Function of 14-3-3 Proteins in Neurodegeneration
por: Shimada, Tadayuki, et al.
Publicado: (2013)

14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer’s Disease Mouse Models
por: Gannon, Mary, et al.
Publicado: (2022)

Spotlight on CYP4B1
por: Röder, Annika, et al.
Publicado: (2023)

14-3-3 Proteins are Regulators of Autophagy
por: Pozuelo-Rubio, Mercedes
Publicado: (2012)

14-3-3γ haploinsufficiency leads to altered dopamine pathway and Parkinson’s disease-like motor incoordination in mice
por: Cho, Eunsil, et al.
Publicado: (2023)

Spotlight on the perioperative use of maropitant citrate
por: Hay Kraus, Bonnie L
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bltplv73gq9cqb5k1mc3rj5ea1